XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization $ 133,584 $ 1,546,534
Acquisition Costs Impairment 1,139,623 147,078
Series Twenty [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty One [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Two [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Three [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Four [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Five [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Six [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Seven [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 261,567
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Eight [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Twenty Nine [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty One [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Two [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Three [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Four [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Five [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Six [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Seven [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Eight [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Thirty Nine [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty One [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment 0 113,304
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty Two [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 69,160
Acquisition Costs Impairment 207,482 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty Three [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 133,584 66,792
Acquisition Costs Impairment 0 0
Remaining Life Acquisition Costs (Years) 3 years  
Series Forty Four [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 1,131,199
Acquisition Costs Impairment 848,390 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty Five [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 17,816
Acquisition Costs Impairment 53,446 0
Remaining Life Acquisition Costs (Years) 0 years  
Series Forty Six [Member]
   
Operating Partnerships Valuation Allowance [Line Items]    
Accumulated Amortization 0 0
Acquisition Costs Impairment $ 30,305 $ 33,774
Remaining Life Acquisition Costs (Years) 0 years